Clinical Trial Update: Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating an investigational neoantigen vaccine for pancreatic cancer has completed, exploring the vaccine in the pre-surgical window.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Neoantigen vaccine (investigational)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreas Cancer, Pancreatic Cancer | Phase 1 | Status: COMPLETED